Chuan An Biotechnology Co., Ltd.   Report issue

For profit Phase 2
Founded: Dongpian Taiwan (1974)

Organization Overview

First Clinical Trial
2017
NCT03124498
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

cytokine induced killer cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1